Skip to content

Government belongs to the people.

If it governs your life, you should have a voice in it.

Official voting resourcesVote.gov ↗USA.gov ↗
All federal
19,826 total · sort: latest action
H.R. 9613 · HOUSE2d
Nuclear Advisory Committee Reform Act
Placed on the Union Calendar, Calendar No. 774.
H.R. 7730 · HOUSE2d
Bankruptcy Threshold Adjustment Act
Presented to President.
H.R. 5723 · HOUSE2d
FRAUD in VA Disability Exams Act
Placed on the Union Calendar, Calendar No. 766.
H.R. 5549 · HOUSE2d
Efficient Nuclear Licensing Hearings Act
Placed on the Union Calendar, Calendar No. 769.
H.R. 1945 · HOUSE2d
America's National Churchill Museum National Historic Landmark Act
Presented to President.
H.R. 3100 · HOUSE2d
CHILD Act of 2026
Placed on the Union Calendar, Calendar No. 770.
H.R. 8205 · HOUSE4d
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Became Public Law No: 119-138.
H.R. 1744 · HOUSE4d
United States Commission on International Religious Freedom Reauthorization Act of 2026
Became Public Law No: 119-137.
H.R. 10953 · HOUSE5d
To direct the Secretary of Heath and Human Services to establish and carry out a program for making allotments to States to pay for the cost of carrying out the State Ombudsman Program to serve as a resource to provide information and support to individuals with developmental disabilities and their families.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Workforce, for a period to be…
H.R. 10952 · HOUSE5d
Health Forests Incentives Act of 2026
Referred to the Committee on Agriculture, and in addition to the Committees on Ways and Means, and Natural Resources, for a period to be…
H.J.Res. 221 · HOUSE5d
Proposing an amendment to the Constitution of the United States giving Congress power to regulate campaign contributions for Federal elections.
Referred to the House Committee on the Judiciary.
H.Res. 1647 · HOUSE5d
Expressing support for the recognition of the week of November 1 through November 7, 2026, as "Drowsy Driving Prevention Week".
Referred to the House Committee on Transportation and Infrastructure.
H.Res. 1646 · HOUSE5d
Supporting the recognition of November as "Bladder Health Awareness Month", supporting efforts to increase public education, reduce stigma, and improve access to care for bladder health conditions, and for other purposes.
Referred to the House Committee on Energy and Commerce.
H.R. 8660 · HOUSE5d
VEST Act
Placed on the Union Calendar, Calendar No. 765.
H.R. 8347 · HOUSE5d
RURAL Healthcare Act
Placed on the Union Calendar, Calendar No. 764.
Showing 15 of 19,826Load 50 more →
119th Congress · H.R. 2821 · Passed Origin

FDA Modernization Act 3.0

This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug. The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications. The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.

0
Voices Recorded
L3 verified 0
L2 verified 0
Why three axes? · 50-second explainer

1 / 10
Now you know how it works.
Your true verified voice
Your Stance
Should this happen?
0%
0%
0%
Fiscal Judgment
Where do you stand on this government spending?
0%
0%
0%
Authority — Multiple can be selected
Which authority should have control over this? Mark all that apply.
0%
0%
0%
0%
SubjectsAdministrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationMedical researchResearch administration and funding

XML scalars

congress
119
type
HR
number
2821
originChamber
House
originChamberCode
H
introducedDate
2025-04-10
updateDate
2026-09-19T23:40:10Z
updateDateIncludingText
2026-09-19T23:40:10Z
title
FDA Modernization Act 3.0
legislationUrl
https://www.congress.gov/bill/119th-congress/house-bill/2821

Constitutional authority statement (CDATA)

[Congressional Record Volume 171, Number 65 (Thursday, April 10, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. CARTER of Georgia:H.R. 2821.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the Constitution[Page H1601]

Pipeline

Track
federal_presidential
Stage
Passed Chamber of Origin
Stage rank
2

Sponsor

  • Rep. Carter, Earl L. "Buddy" [R-GA-1] · [R-GA-1] · C001103
    Rep-GA-1 current · 6 terms · @RepBuddyCarter · 2 district offices

Sponsor record (congress_legislators)

Bio (legislators)

bioguide
C001103
status
current
official_full
Earl L. "Buddy" Carter
first
Earl
middle
L.
last
Carter
suffix
null
nickname
Buddy
birthday
1957-09-06
gender
M

Current term (6 total)

type
rep
state
GA
district
1
class
null
party
Republican
caucus
null
start
2025-01-03
end
2027-01-03
end_type
null
how
null
url
https://buddycarter.house.gov
address
2432 Rayburn House Office Building Washington DC 20515-1001
office
2432 Rayburn House Office Building
phone
202-225-5831
fax
null
contact_form
null
rss_url
null

Leadership roles (0)

none

Committee memberships (5)

  • Communications and Technology (house) · house · rank 6
  • Environment (house) · house · rank 5
  • Health (house) · house · rank 4
  • House Committee on Energy and Commerce (house) · house · rank 6 · site
  • House Committee on the Budget (house) · house · rank 6 · site

Social media

District offices (2)

  • 6602 Abercorn St., Suite 105B, Savannah, GA, 31405 · 912-352-0101 · fax 912-352-0105 · 32.017594,-81.11040299999999
  • 777 Gloucester Street, Suite 410, Brunswick, GA, 31520 · 912-265-9010 · fax 912-265-9013 · 31.15005,-81.49307019999999

Other names (0)

none

Sponsor FEC record (fec_live)

Candidate record (candidates) · cycle 2026

candidate_id
H4GA01039
cycle
2026
name
CARTER, EARL LEROY
party
REPUBLICAN PARTY
office
House
state
GA
district
01
incumbent_challenge
Incumbent
candidate_status
C
active_through
2026
election_year
null
first_file_date
2013-04-23
last_file_date
2024-11-18
last_f2_date
2024-11-18
address
null

Candidate summary (candidate_summaries) · cycle 2026

cycle
2026
total_receipts
null
total_disbursements
null
cash_on_hand_end_period
$0.00
debts_owed_by_committee
$0.00
coverage_start_date
null
coverage_end_date
null

Connected committees (0)

none

Cosponsors (41)

  • Rep. Barragán, Nanette Diaz [D-CA-44] · [D-CA-44] · B001300 · Co-sponsored 2025-04-10 · original
    Dem-CA-44 current · 5 terms · @RepBarragan · 4 district offices
  • Rep. Buchanan, Vern [R-FL-16] · [R-FL-16] · B001260 · Co-sponsored 2025-04-10 · original
    Rep-FL-16 current · 10 terms · @VernBuchanan · 3 district offices
  • Rep. DeLauro, Rosa L. [D-CT-3] · [D-CT-3] · D000216 · Co-sponsored 2025-04-10 · original
    Dem-CT-3 current · 18 terms · @RosaDeLauro · 1 district office
  • Rep. Harshbarger, Diana [R-TN-1] · [R-TN-1] · H001086 · Co-sponsored 2025-04-10 · original
    Rep-TN-1 current · 3 terms · @RepHarshbarger · 2 district offices
  • Rep. Carter, Troy A. [D-LA-2] · [D-LA-2] · C001125 · Co-sponsored 2025-04-10 · original
    Dem-LA-2 current · 3 terms · @RepTroyCarter · 6 district offices
  • Rep. Doggett, Lloyd [D-TX-37] · [D-TX-37] · D000399 · Co-sponsored 2025-04-14
    Dem-TX-37 current · 16 terms · @RepLloydDoggett · 1 district office
  • Rep. Nadler, Jerrold [D-NY-12] · [D-NY-12] · N000002 · Co-sponsored 2025-04-17
    Dem-NY-12 current · 18 terms · @RepJerryNadler · 1 district office
  • Rep. Carey, Mike [R-OH-15] · [R-OH-15] · C001126 · Co-sponsored 2025-04-17
    Rep-OH-15 current · 3 terms · @RepMikeCarey · 1 district office
  • Rep. Fitzpatrick, Brian K. [R-PA-1] · [R-PA-1] · F000466 · Co-sponsored 2025-04-17
    Rep-PA-1 current · 5 terms · @RepBrianFitz · 1 district office
  • Rep. Malliotakis, Nicole [R-NY-11] · [R-NY-11] · M000317 · Co-sponsored 2025-04-17
    Rep-NY-11 current · 3 terms · @RepMalliotakis · 2 district offices
  • Rep. Crenshaw, Dan [R-TX-2] · [R-TX-2] · C001120 · Co-sponsored 2025-04-17
    Rep-TX-2 current · 4 terms · @RepDanCrenshaw · 2 district offices
  • Rep. Chu, Judy [D-CA-28] · [D-CA-28] · C001080 · Co-sponsored 2025-04-29
    Dem-CA-28 current · 9 terms · @RepJudyChu · 2 district offices
  • Rep. Scholten, Hillary J. [D-MI-3] · [D-MI-3] · S001221 · Co-sponsored 2025-04-29
    Dem-MI-3 current · 2 terms · @RepScholten · 1 district office
  • Rep. Soto, Darren [D-FL-9] · [D-FL-9] · S001200 · Co-sponsored 2025-04-29
    Dem-FL-9 current · 5 terms · @RepDarrenSoto · 2 district offices
  • Rep. Goldman, Daniel S. [D-NY-10] · [D-NY-10] · G000599 · Co-sponsored 2025-04-29
    Dem-NY-10 current · 2 terms · @RepDanGoldman · 2 district offices
  • Rep. Obernolte, Jay [R-CA-23] · [R-CA-23] · O000019 · Co-sponsored 2025-05-13
    Rep-CA-23 current · 3 terms · @JayObernolte · 1 district office
  • Rep. Gottheimer, Josh [D-NJ-5] · [D-NJ-5] · G000583 · Co-sponsored 2025-05-20
    Dem-NJ-5 current · 5 terms · @RepJoshG · 7 district offices
  • Rep. Crow, Jason [D-CO-6] · [D-CO-6] · C001121 · Co-sponsored 2025-06-06
    Dem-CO-6 current · 4 terms · @RepJasonCrow · 1 district office
  • Rep. Lieu, Ted [D-CA-36] · [D-CA-36] · L000582 · Co-sponsored 2025-06-27
    Dem-CA-36 current · 6 terms · @RepTedLieu · 2 district offices
  • Rep. Tenney, Claudia [R-NY-24] · [R-NY-24] · T000478 · Co-sponsored 2025-07-02
    Rep-NY-24 current · 4 terms · @RepTenney · 4 district offices
  • Rep. Smith, Christopher H. [R-NJ-4] · [R-NJ-4] · S000522 · Co-sponsored 2025-07-02
    Rep-NJ-4 current · 23 terms · 2 district offices
  • Del. Norton, Eleanor Holmes [D-DC-At Large] · [D-DC-0] · N000147 · Co-sponsored 2025-07-10
    Dem-DC current · 18 terms · @EleanorNorton · 1 district office
  • Rep. Salazar, Maria Elvira [R-FL-27] · [R-FL-27] · S000168 · Co-sponsored 2025-07-10
    Rep-FL-27 current · 3 terms · @RepMariaSalazar · 3 district offices
  • Rep. Frankel, Lois [D-FL-22] · [D-FL-22] · F000462 · Co-sponsored 2025-07-14
    Dem-FL-22 current · 7 terms · @RepLoisFrankel · 1 district office
  • Rep. Valadao, David G. [R-CA-22] · [R-CA-22] · V000129 · Co-sponsored 2025-07-14
    Rep-CA-22 current · 6 terms · @RepDavidValadao · 2 district offices
  • Rep. Harder, Josh [D-CA-9] · [D-CA-9] · H001090 · Co-sponsored 2025-07-14
    Dem-CA-9 current · 4 terms · @RepJoshHarder · 1 district office
  • Rep. Fitzgerald, Scott [R-WI-5] · [R-WI-5] · F000471 · Co-sponsored 2025-07-16
    Rep-WI-5 current · 3 terms · @RepFitzgerald · 1 district office
  • Rep. Bilirakis, Gus M. [R-FL-12] · [R-FL-12] · B001257 · Co-sponsored 2025-07-16
    Rep-FL-12 current · 10 terms · @RepGusBilirakis · 3 district offices
  • Rep. Lee, Laurel M. [R-FL-15] · [R-FL-15] · L000597 · Co-sponsored 2025-07-17
    Rep-FL-15 current · 2 terms · @RepLaurelLee · 1 district office
  • Rep. Calvert, Ken [R-CA-41] · [R-CA-41] · C000059 · Co-sponsored 2025-07-22
    Rep-CA-41 current · 17 terms · @KenCalvert · 2 district offices
  • Rep. Vindman, Eugene Simon [D-VA-7] · [D-VA-7] · V000138 · Co-sponsored 2025-09-11
    Dem-VA-7 current · 1 term · @RepVindman · 1 district office
  • Rep. Pocan, Mark [D-WI-2] · [D-WI-2] · P000607 · Co-sponsored 2025-11-04
    Dem-WI-2 current · 7 terms · @RepMarkPocan · 1 district office
  • Rep. Lawler, Michael [R-NY-17] · [R-NY-17] · L000599 · Co-sponsored 2025-11-20
    Rep-NY-17 current · 2 terms · @RepMikeLawler · 2 district offices
  • Rep. Weber, Randy K. Sr. [R-TX-14] · [R-TX-14] · W000814 · Co-sponsored 2025-12-02
    Rep-TX-14 current · 7 terms · @TXRandy14 · 3 district offices
  • Rep. Neguse, Joe [D-CO-2] · [D-CO-2] · N000191 · Co-sponsored 2025-12-11
    Dem-CO-2 current · 4 terms · @RepJoeNeguse · 3 district offices
  • Rep. Krishnamoorthi, Raja [D-IL-8] · [D-IL-8] · K000391 · Co-sponsored 2025-12-15
    Dem-IL-8 current · 5 terms · @CongressmanRaja · 1 district office
  • Rep. Kean, Thomas H. [R-NJ-7] · [R-NJ-7] · K000398 · Co-sponsored 2026-01-07
    Rep-NJ-7 current · 2 terms · @CongressmanKean · 6 district offices
  • Rep. Johnson, Julie [D-TX-32] · [D-TX-32] · J000310 · Co-sponsored 2026-01-15
    Dem-TX-32 current · 1 term · @RepJulieJohnson · 1 district office
  • Rep. Kim, Young [R-CA-40] · [R-CA-40] · K000397 · Co-sponsored 2026-04-22
    Rep-CA-40 current · 3 terms · @RepYoungKim · 2 district offices
  • Rep. Langworthy, Nicholas A. [R-NY-23] · [R-NY-23] · L000600 · Co-sponsored 2026-05-12
    Rep-NY-23 current · 2 terms · @RepLangworthy · 4 district offices
  • Rep. Thanedar, Shri [D-MI-13] · [D-MI-13] · T000488 · Co-sponsored 2026-06-02
    Dem-MI-13 current · 2 terms · @RepShriThanedar · 1 district office

Committees (1)

  • Energy and Commerce Committee [House Standing]
    2026-06-18T14:29:12ZReported By
    2026-05-21T13:50:47ZMarkup By
    2025-04-10T13:10:10ZReferred To
    ↳ Health Subcommittee

Actions — from XML (18)

  • 2026-07-21IntroReferralvia Senate
    Received in the Senate.
  • 2026-07-20 14:57:23FloorH38310via House floor actions
    Motion to reconsider laid on the table Agreed to without objection.
  • 2026-07-20 14:57:19FloorH37300via House floor actions
    On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
  • 2026-07-20 14:57:19Floor8000via Library of Congress
    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
  • 2026-07-20 14:47:33FloorH8D000via House floor actions
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
  • 2026-07-20 14:47:31FloorH30000via House floor actions
    Considered under suspension of the rules. (consideration: CR H4639-4640)
  • 2026-07-20 14:47:16FloorH30300via House floor actions
    Mr. Guthrie moved to suspend the rules and pass the bill.
  • 2026-06-18CalendarsH12410via House floor actions
    Placed on the Union Calendar, Calendar No. 614.
  • 2026-06-18CommitteeH12200via House floor actions
    Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
  • 2026-06-18Committee5000via Library of Congress
    Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
  • 2026-05-21Committeevia House committee actions
    Ordered to be Reported by the Yeas and Nays: 44 - 0.
  • 2026-05-21Committeevia House committee actions
    Committee Consideration and Mark-up Session Held
  • 2026-05-13Committeevia House committee actions
    Forwarded by Subcommittee to Full Committee by Voice Vote.
  • 2026-05-13Committeevia House committee actions
    Subcommittee Consideration and Mark-up Session Held
  • 2026-04-10Committeevia House committee actions
    Referred to the Subcommittee on Health.
  • 2025-04-10IntroReferralH11100via House floor actions
    Referred to the House Committee on Energy and Commerce.
  • 2025-04-10IntroReferralIntro-Hvia Library of Congress
    Introduced in House
  • 2025-04-10IntroReferral1000via Library of Congress
    Introduced in House

Actions — from bill_actions table (0)

none

Titles

  • Display Title2026-09-19T23:40:10Z
    FDA Modernization Act 3.0
  • Short Title(s) as Passed HouseEHH2026-07-22T05:38:24Z
    FDA Modernization Act 3.0
  • Official Title from EH (Engrossed in House) bill textEHH2026-07-22T05:38:24Z
    To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.
  • Short Title(s) as Reported to HouseRHH2026-06-19T04:53:21Z
    FDA Modernization Act 3.0
  • Short Title(s) as IntroducedIH2025-04-25T13:23:34Z
    FDA Modernization Act 3.0
  • Official Title as IntroducedIH2025-04-25T13:18:20Z
    To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.

Text versions (from XML)

Versions — from bill_versions table (0)

none

Policy area

Health

Summaries

00 · 2025-04-10 · Introduced in House

FDA Modernization Act 3.0

This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug. 

The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications. 

The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule. 

Related bills

  • S 355 (119) FDA Modernization Act 3.0
    Latest: 2025-12-17 — Held at the desk.
    Relationship: Identical bill (via CRS)

Amendments (0)

none

Laws

none

Committee reports

  • H. Rept. 119-706

Calendar number

null

CBO cost estimates

none

Latest action

Date
2026-07-21
Text
Received in the Senate.
Time
null

Dublin Core

format
text/xml
language
EN
rights
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
contributor
Congressional Research Service, Library of Congress
description
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.

Row fields (debug)

id
2881
congress
119
bill_type
hr
bill_number
2821
bill_slug
hr-2821-119
title
FDA Modernization Act 3.0
short_title
FDA Modernization Act 3.0
sponsor_bioguide_id
C001103
sponsor_name
Rep. Carter, Earl L. "Buddy" [R-GA-1]
sponsor_party
R
sponsor_state
GA
introduced_date
2025-04-10
latest_action_date
2026-07-21
latest_action_text
Received in the Senate.
status
null
policy_area
Health
subjects_json
[
  "Administrative law and regulatory procedures",
  "Department of Health and Human Services",
  "Drug safety, medical device, and laboratory regulation",
  "Medical research",
  "Research administration and funding"
]
govinfo_billstatus_path
BILLSTATUS-119hr2821
raw_billstatus_xml
<?xml version="1.0" encoding="utf-8" standalone="no"?> <billStatus> <version>3.0.0</version> <bill> <number>2821</number> <updateDate>2026-09-19T23:40:10Z</updateDate> <updateDateIncludingText>2026-09-19T23:40:10Z</updateDateIncludingText> <originChamber>House</originChamber> <originChamberCode>H</originChamberCode> <type>HR</type> <introducedDate>2025-04-10</int…
summary_lede
This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug. The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests…
topic_primary
health
topic_secondary_json
[]
action_family
introduced_only
response_available
0
response_type
null
response_deadline
null
importance_score
null
consequence_score
null
urgency_score
null
overall_score
null
in_canopy
0
canopy_expires_at
null
pipeline_track
federal_presidential
pipeline_stage
passed_origin
pipeline_stage_rank
2
stable_action_id
hr-2821-119
jurisdiction
federal
lock_status
open
lock_at
null
content_hash
86ff35114850229771bde252e95de01f5c69a69fd793dbe1326842fcd7138800
anchored_at
null
anchor_merkle_root
null
source_kind
api_fill
first_seen_at
2026-04-20T08:15:57.988066+00:00
last_seen_at
2026-09-27T11:30:22.070413+00:00
⎔ Anchored0x0000…0000Epoch 2026-Q4